StrainX raises $13.0M (May 2026)
Reach the investors backing rounds like this
Backed by Prime Venture Partners, Leo Capital · verified emails and LinkedIn on Datapile
Synthetic biology startup StrainX raises $13 million in funding from Prime Venture Partners, Leo Capital - Moneycontrol.com
StrainX is a synthetic biology startup focused on developing innovative solutions in the field of biotechnology. The company aims to leverage advanced biological engineering techniques to create new products and processes. This funding round will help StrainX accelerate its growth and expand its research capabilities.
Synthetic biology startup StrainX raises $13 million in funding from Prime Venture Partners, Leo Capital Moneycontrol.com
| Sep 18, 2026 | Louisiana Innovation (LA.IO) | $7.5M | Grant | United States |
| Sep 17, 2026 | Gaoyu | $120.0M | Series A | — |
| Sep 17, 2026 | Causey | $2.7M | — | United Kingdom |
| Sep 17, 2026 | DheyaTech | $5.8M | Pre-Series A | — |
Find the investors behind rounds like this one
You just read who funded StrainX. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.